Loading stock data…
$142.41-1.43 (-0.99%)
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Novartis AG in the Healthcare sector is trading at $142.41 with a market capitalization of $297.1B. Wall Street consensus targets $154.65 (11 analysts), implying a +8.6% move over the next 12 months. The stock is currently 16% below its 52-week high of $170.46, remaining 4.9% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $14.95B↑ | $13.52B↓ | $13.86B↓ | $14.36B↓ | $14.84B |
| Gross Profit | $11.24B↑ | $10.06B↓ | $10.25B↓ | $10.82B↓ | $11.51B |
| Operating Income | $4.75B↑ | $4.24B↑ | $3.62B↓ | $4.50B↓ | $4.86B |
| Net Income | $3.26B↑ | $3.16B↑ | $2.41B↓ | $3.93B↓ | $4.04B |
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart f...